Scholarlink

<p>Congenital tooth agenesis, including hypodontia and oligodontia, represents one of the most common developmental anomalies of the craniofacial complex and reflects failure of odontogenesis rather than postnatal tissue degeneration. The absence of teeth during growth affects mastication, speech, facial development and psychosocial well-being, while current management remains limited to prolonged temporization during childhood followed by definitive prosthetic rehabilitation after craniofacial maturation. No curative therapy is presently available. Recent advances in cell biology and developmental genetics have renewed interest in regenerative strategies for congenital organ defects. In this context, tooth agenesis provides a stringent model to examine the feasibility of stem cell-based interventions in conditions governed by tightly regulated embryonic programs. Two principal paradigms have emerged: (1) whole-tooth replacement via bioengineering strategies that attempt to reconstruct odontogenic processes ex vivo, and (2) endogenous developmental reactivation approaches that seek to permissively modulate molecular checkpoints within existing odontogenic substrates. While whole-tooth bioengineering has demonstrated proof-of-concept in experimental models, their clinical translation remains constrained by morphogenetic complexity and early genetic specification. In contrast, increasing evidence identifies USAG-1, a dual BMP/Wnt antagonist, as a developmental gatekeeper regulating tooth number and progression. Preclinical studies indicate that anti–USAG-1 antibody administration can rescue tooth germs whose development stopped and induce supernumerary tooth formation in vivo, suggesting that, under restricted conditions, continuation of odontogenesis beyond embryonic checkpoints may be biologically achievable. However, such strategies depend on permissive genetic and temporal contexts therefore require careful consideration of safety, pediatric ethics and long-term craniofacial integration. By integrating developmental biology, human genetics, and regenerative medicine, this review delineates the biological boundaries that govern these strategies and highlights why future advances are more likely to arise from precise modulation of developmental constraints in carefully stratified patient populations than from de novo tooth reconstruction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Stem Cell-based Therapeutic and Endogenous Regeneration Approaches for Congenital Tooth Agenesis

  • 期刊论文

  • 发表日期：

    2026年5月21日

查看全文
  • Pierre-Yves Collart-Dutilleul,
  • Damien Veret,
  • Richard Younes,
  • Estelle Moulis,
  • Frédéric Cuisinier,
  • Clara Joseph,
  • Azel Zine

摘要

Congenital tooth agenesis, including hypodontia and oligodontia, represents one of the most common developmental anomalies of the craniofacial complex and reflects failure of odontogenesis rather than postnatal tissue degeneration. The absence of teeth during growth affects mastication, speech, facial development and psychosocial well-being, while current management remains limited to prolonged temporization during childhood followed by definitive prosthetic rehabilitation after craniofacial maturation. No curative therapy is presently available. Recent advances in cell biology and developmental genetics have renewed interest in regenerative strategies for congenital organ defects. In this context, tooth agenesis provides a stringent model to examine the feasibility of stem cell-based interventions in conditions governed by tightly regulated embryonic programs. Two principal paradigms have emerged: (1) whole-tooth replacement via bioengineering strategies that attempt to reconstruct odontogenic processes ex vivo, and (2) endogenous developmental reactivation approaches that seek to permissively modulate molecular checkpoints within existing odontogenic substrates. While whole-tooth bioengineering has demonstrated proof-of-concept in experimental models, their clinical translation remains constrained by morphogenetic complexity and early genetic specification. In contrast, increasing evidence identifies USAG-1, a dual BMP/Wnt antagonist, as a developmental gatekeeper regulating tooth number and progression. Preclinical studies indicate that anti–USAG-1 antibody administration can rescue tooth germs whose development stopped and induce supernumerary tooth formation in vivo, suggesting that, under restricted conditions, continuation of odontogenesis beyond embryonic checkpoints may be biologically achievable. However, such strategies depend on permissive genetic and temporal contexts therefore require careful consideration of safety, pediatric ethics and long-term craniofacial integration. By integrating developmental biology, human genetics, and regenerative medicine, this review delineates the biological boundaries that govern these strategies and highlights why future advances are more likely to arise from precise modulation of developmental constraints in carefully stratified patient populations than from de novo tooth reconstruction.